On April 15, 2026, the UK government published its renewed Women's Health Strategy for England, anchored by a £1.5 million FemTech Challenge Fund designed to accelerate adoption of technologies that could transform women's healthcare. Health Secretary Wes Streeting, who declared that the NHS "too often gaslights women, treating their pain as an inconvenience," announced the fund alongside a sweeping set of commitments across gynaecology, menopause, and reproductive care. The challenge fund provides grant awards directly to NHS systems to work alongside promising FemTech developers — with an explicit focus on community service models addressing health inequalities.

Why It Matters

A £1.5M government-backed challenge fund with direct NHS integration pathways is a meaningful structural step for UK FemTech. Unlike traditional grant programmes, this model requires NHS systems to co-develop solutions with developers — creating built-in adoption pipelines. For companies with products addressing menopause, endometriosis, and pelvic health, this represents an institutional on-ramp that could validate products for clinical settings across Europe. The Wes Streeting framing — that the NHS systematically dismisses women's pain — gives the strategy political force that prior versions lacked, and the India partnership signals the UK is competing globally for femtech positioning post-Brexit.

The challenge fund sits within a much larger policy package. The strategy commits to cutting gynaecology waiting lists — currently at 565,000 women in England — by creating a single referral point directing patients to the right professional first time. NHS Online is being expanded to support management of menstrual and menopausal symptoms. A new £1 million menstrual health education programme will help girls recognize signs of conditions like endometriosis and PCOS earlier. NHS Health Checks for adults aged 40-74 now include menopause symptom screening, making that a mainstream clinical touchpoint for the first time.

Beyond the challenge fund itself, the strategy includes a new accelerator for female founders through the National Institute for Health and Care Research (NIHR), offering funding, mentoring, and commercial support for innovations aligned with NHS priorities. A collaboration with India's Department of Biotechnology on femtech research was also announced, and new standards will require that publicly funded research account for sex-based biological differences — closing a data gap that has long hampered women's health innovation.

The challenge fund model is specifically designed to generate NHS evidence for FemTech products seeking pathway to national adoption — addressing one of the sector's most persistent bottlenecks, in which promising devices and apps struggle to prove clinical utility in NHS settings. The fund will complement wearable technology trials initially targeting cardiovascular disease detection in deprived areas, signaling the government's intent to use FemTech as an equity tool, not just an innovation showcase.

Sources

Update — 2026-04-17

Initial entry — story first created.